[{"address1": "2656 State Street", "city": "Carlsbad", "state": "CA", "zip": "92008", "country": "United States", "phone": "619 728 4760", "website": "https://tyra.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SN\u00c5P, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Dr. Todd  Harris Ph.D.", "age": 45, "title": "Co-Founder, President, CEO, Secretary, Treasurer & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 1067050, "exercisedValue": 0, "unexercisedValue": 7050750}, {"maxAge": 1, "name": "Mr. Daniel  Bensen", "age": 49, "title": "Co-Founder & COO", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 737643, "exercisedValue": 0, "unexercisedValue": 4335961}, {"maxAge": 1, "name": "Dr. Douglas  Warner M.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 627900, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alan  Fuhrman CPA", "age": 67, "title": "Chief Financial Officer", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 763093, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert L. Hudkins Ph.D.", "age": 69, "title": "Chief Technology Officer", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ronald V. Swanson Ph.D.", "age": 61, "title": "Chief Scientific Officer", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 536188, "exercisedValue": 0, "unexercisedValue": 298928}, {"maxAge": 1, "name": "Mr. Ali D. Fawaz J.D.", "title": "General Counsel", "fiscalYear": 2024, "totalPay": 629230, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Honig", "title": "Senior VP of Corporate Development & Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Liz  Pagano", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Piyush R. Patel Ph.D.", "age": 59, "title": "Chief Development Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 14.12, "open": 14.39, "dayLow": 14.145, "dayHigh": 14.99, "regularMarketPreviousClose": 14.12, "regularMarketOpen": 14.39, "regularMarketDayLow": 14.145, "regularMarketDayHigh": 14.99, "payoutRatio": 0.0, "beta": 1.112, "forwardPE": -7.044554, "volume": 130965, "regularMarketVolume": 130965, "averageVolume": 209612, "averageVolume10days": 246610, "averageDailyVolume10Day": 246610, "bid": 14.13, "ask": 14.29, "bidSize": 1, "askSize": 1, "marketCap": 758418304, "fiftyTwoWeekLow": 6.42, "fiftyTwoWeekHigh": 22.64, "allTimeHigh": 31.36, "allTimeLow": 4.93, "fiftyDayAverage": 12.8992, "twoHundredDayAverage": 11.43205, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 468170304, "profitMargins": 0.0, "floatShares": 17218174, "sharesOutstanding": 53297140, "sharesShort": 5782614, "sharesShortPriorMonth": 5952493, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.108500004, "heldPercentInsiders": 0.03681, "heldPercentInstitutions": 1.0661399, "shortRatio": 32.07, "shortPercentOfFloat": 0.159, "impliedSharesOutstanding": 53297140, "bookValue": 5.676, "priceToBook": 2.5070472, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -105832000, "trailingEps": -1.79, "forwardEps": -2.02, "enterpriseToEbitda": -3.867, "52WeekChange": -0.2845651, "SandP52WeekChange": 0.16625166, "quoteType": "EQUITY", "currentPrice": 14.23, "targetHighPrice": 36.0, "targetLowPrice": 28.0, "targetMeanPrice": 32.0, "targetMedianPrice": 32.0, "recommendationKey": "none", "numberOfAnalystOpinions": 7, "totalCash": 296271008, "totalCashPerShare": 5.559, "ebitda": -121072000, "totalDebt": 6023000, "quickRatio": 21.639, "currentRatio": 21.943, "debtToEquity": 1.993, "returnOnAssets": -0.21294, "returnOnEquity": -0.3121, "freeCashflow": -46264248, "operatingCashflow": -86626000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TYRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Tyra Biosciences, Inc.", "priceEpsCurrentYear": -7.129258, "fiftyDayAverageChange": 1.3307991, "fiftyDayAverageChangePercent": 0.10316911, "twoHundredDayAverageChange": 2.7979498, "twoHundredDayAverageChangePercent": 0.24474612, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1631712600000, "postMarketChangePercent": 0.0, "postMarketPrice": 14.23, "postMarketChange": 0.0, "regularMarketChange": 0.11, "regularMarketDayRange": "14.145 - 14.99", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 209612, "fiftyTwoWeekLowChange": 7.8099995, "fiftyTwoWeekLowChangePercent": 1.2165108, "fiftyTwoWeekRange": "6.42 - 22.64", "fiftyTwoWeekHighChange": -8.41, "fiftyTwoWeekHighChangePercent": -0.37146643, "fiftyTwoWeekChangePercent": -28.456509, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.79, "epsForward": -2.02, "epsCurrentYear": -1.996, "marketState": "CLOSED", "longName": "Tyra Biosciences, Inc.", "corporateActions": [], "postMarketTime": 1761336604, "regularMarketTime": 1761336000, "exchange": "NMS", "messageBoardId": "finmb_650787124", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.779034, "regularMarketPrice": 14.23, "trailingPegRatio": null, "__fetch_time": "2025-10-25"}]